Press / media

Researchers of Fraunhofer Institute for Cell Therapy and Immunology have published a review of the current global research and development status of non-viral vectors for producing CAR-T cells in the Nature Reviews Methods Primers journal.

The Fraunhofer Institute for Cell Therapy and Immunology IZI is a practice partner of the QualiBioPharma qualification program. The program, which is initiated and coordinated by biosaxony Management GmbH, was honored as "ClusterERFOLG" – cluster success – of the year 2024 at the "go-cluster" conference at the German Federal Ministry of Economics and Climate Protection (BMWK) on September 12, 2024.

The Saxon SaxoCell future cluster is pleased to announce that it has been selected for the second funding phase by the Federal Ministry of Education and Research (BMBF). This decision by the ministry highlights the potential, as well as the successes, of SaxoCell, the pioneering cluster for innovative cell and gene therapies.

The Executive Board of Dresden Technical University has appointed PD Dr Stephan Fricke, Head of the Department of Cell and Gene Therapy Development, as adjunct professor at the TUD Faculty of Medicine with effect from 21 May 2024.